Boron tribromide → HCID 136140058, compound
Reaction equation
C[O:2][C:3]1[CH:4]=[C:5]([C:13]2[N:22]=[C:21]([NH2:23])[C:20]3[C:15](=[CH:16][CH:17]=[CH:18][CH:19]=3)[N:14]=2)[CH:6]=[C:7]([O:11]C)[C:8]=1[O:9]C.B(Br)(Br)Br>C(Cl)Cl>[C:5]1([CH3:13])[CH:6]=[CH:7][C:8]([NH:23][C:21]2[C:20]3[C:15](=[CH:16][CH:17]=[CH:18][CH:19]=3)[N:14]=[C:13]([C:5]3[CH:6]=[C:7]([OH:11])[C:8]([OH:9])=[C:3]([OH:2])[CH:4]=3)[N:22]=2)=[CH:3][CH:4]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
An aryl methoxy derivative p-tolyl-[2-(3,4,5-trimethoxy-phenyl)-quinazolin-4-yl]-amine (2, 30 mg, 7.5e-5 mol) was dissolved in anhydrous DCM (minimal volume, not fully dissolved); the round flask was then sealed. BBr3 (76 μl, 0.111 gr, 205 gr/mol, d=1.45, 2 equiv/per methoxy group, here 6 eq. were used 5.5e-4 mol) was added drop wise (from a syringe) and the reaction mixture was stirred at room temperature for 1 h. The degree of conversion was monitored by HPLC until full conversion was achieved, and the reaction was then quenched with methanol and evaporated to low volume. Another wash was performed using methanol, followed by a wash with acetonitrile and evaporation, to obtain 5-(4-(p-tolylamino)quinazolin-2-yl)benzene-1,2,3-triol, 21 (24 mg, 6.6e-5 mol, 90%). m.p>250° C.; 1H NMR (300 MHz, DMSO-d6) δ 2.35 (s, 3H), 6.75 (s, 2H), 7.22 (d, J=8.0 Hz, 2H), 7.35 (d, J=7.5 Hz, 2H), 7.56 (t, J=8.0 Hz, H), 7.82 (t, J=8.2 Hz, 2H), 8.24 (d, J=7.5 Hz, 1H). Anal. (C21H17N3O3) C, H, N.
Workup
- dissolutionnot fully dissolved)
- customthe round flask was then sealed
- additionwas added drop wise (from a syringe)
- customthe reaction was then quenched with methanol
- customevaporated to low volume
- washa wash with acetonitrile and evaporation
Sources & evidence
- ORD record
- ord-747f0c68711544b5beb822fe3f77c39f
- Source dataset
- uspto-grants-2014_06
- Patent number
- US08759363B2
Reaction notes
Loading…